{"disease":{"id":"pte-pulmonary-thromboembolism","name":"pte pulmonary thromboembolism"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT03185377","title":"Registry for Chronic Obstructive Pulmonary Disease With Pulmonary Thromboembolism in China","phase":"","overall_status":"UNKNOWN","enrollment_count":1708,"lead_sponsor_name":"Chinese Academy of Medical Sciences, Fuwai Hospital","has_results":false},{"nct_id":"NCT03185845","title":"The Appropriate Anticoagulation Duration for Chronic Obstructive Pulmonary Disease With Pulmonary Thromboembolism","phase":"NA","overall_status":"UNKNOWN","enrollment_count":392,"lead_sponsor_name":"Chinese Academy of Medical Sciences, Fuwai Hospital","has_results":false}],"total":2},"guidelines":[],"source":"Drug Landscape verified database"}